Category: accelerated pathways

  • Lawmakers eye affordability in push for expanded Alzheimer’s treatment

    Lawmakers on Tuesday said too many hurdles remain between Alzheimer’s patients and emerging medications that could slow their deterioration, due to both the high cost of new drugs and the limited response from Congress and regulatory agencies to expand access to them.   Rep. Brad Wenstrup (R-Ohio), co-chair of the GOP Doctors Caucus, said the high […]